Memorializing Governor Kathy Hochul to proclaim July 2026, as Fibroid Awareness Month in the State of New York
This resolution memorializes Governor Kathy Hochul to proclaim July 2026 as Fibroid Awareness Month in New York State. It is a nonbinding commemorative measure that expresses the Legislature’s support for raising awareness of uterine fibroids, a common benign condition affecting the uterus and a leading cause of hysterectomy. The resolution emphasizes the health burden of fibroids, including their prevalence, especially among African American women, and the need for greater public education and attention to treatment options.
The resolution also highlights the economic and medical costs associated with fibroid-related care, including hospitalizations, surgeries, lost work time, and broader health system expenses. It suggests that awareness efforts such as seminars, funding opportunities, medical information panels, and community programs could help promote earlier diagnosis, research, improved treatments, and ultimately a cure. The measure does not create a new program, mandate services, or change eligibility for benefits; instead, it seeks an executive proclamation and public recognition of the issue.
Because this is a Senate resolution memorializing the Governor, it does not amend the Consolidated Laws or create enforceable rights, duties, or appropriations. Its practical effect is symbolic and promotional: it encourages state recognition of fibroid awareness and may help support public health outreach, advocacy, and education efforts by state agencies, health organizations, and community groups. The resolution’s focus is on women’s health and disparities in fibroid incidence and treatment, particularly affecting African American women.
The overall sentiment is strongly supportive and affirmative. The resolution frames fibroid awareness as an important women’s health issue and presents the proclamation as a constructive step toward education, research, and better care. No votes or committee transcripts were provided, and the bill history shows no recorded opposition or controversy in the available materials.
No direct contention is evident in the provided record. Because the measure is a ceremonial resolution rather than a regulatory bill, there are no identified disputes over mandates, funding, or statutory changes. The only substantive policy emphasis is on the need for greater awareness, research, and outreach regarding uterine fibroids, with particular attention to racial disparities in prevalence and outcomes.